“Effects of pitavastatin (LIVALO Tablet) on high density lipoprotein cholesterol (HDL-C) in hypercholesterolemia.”. J Atheroscler Thromb.16: 654–61. (Oct 2009). doi:10.5551/jat.1719. PMID19907105.
Kawashiri, MA; Nohara, A; Tada, H; Mori, M; Tsuchida, M; Katsuda, S; Inazu, A; Kobayashi, J et al. (May 2008). “Comparison of effects of pitavastatin and atorvastatin on plasma coenzyme Q10 in heterozygous familial hypercholesterolemia: results from a crossover study”. Clin Pharmacol Ther.83 (5): 731–9. doi:10.1038/sj.clpt.6100396. PMID17957184.
Ogata, N.; Fujimori, S.; Oka, Y.; Kaneko, K. (2010). “Effects of Three Strong Statins (Atorvastatin, Pitavastatin, and Rosuvastatin) on Serum Uric Acid Levels in Dyslipidemic Patients”. Nucleosides, Nucleotides and Nucleic Acids29 (4–6): 321. doi:10.1080/15257771003741323.
Kajinami, K; Takekoshi, N; Saito, Y (2003). “Pitavastatin: efficacy and safety profiles of a novel synthetic HMG-CoA reductase inhibitor”. Cardiovascular drug reviews21 (3): 199–215. PMID12931254.
“Effects of pitavastatin (LIVALO Tablet) on high density lipoprotein cholesterol (HDL-C) in hypercholesterolemia.”. J Atheroscler Thromb.16: 654–61. (Oct 2009). doi:10.5551/jat.1719. PMID19907105.
Kawashiri, MA; Nohara, A; Tada, H; Mori, M; Tsuchida, M; Katsuda, S; Inazu, A; Kobayashi, J et al. (May 2008). “Comparison of effects of pitavastatin and atorvastatin on plasma coenzyme Q10 in heterozygous familial hypercholesterolemia: results from a crossover study”. Clin Pharmacol Ther.83 (5): 731–9. doi:10.1038/sj.clpt.6100396. PMID17957184.
